<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: ovarian cancer</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Pancreatic tumors are marked for immunotherapy</title>
   	 <description>Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.</description>
     <link>http://www.physorg.com/news178823918.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Nov 2009 17:30:02 EST</pubDate>
	 <guid isPermaLink="false">news178823918</guid>
</item>
<item>
     <title>FDA approved leukemia drugs shows promise in ovarian cancer cells</title>
   	 <description>The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.</description>
     <link>http://www.physorg.com/news177076257.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 10 Nov 2009 12:30:02 EST</pubDate>
	 <guid isPermaLink="false">news177076257</guid>
</item>
<item>
     <title>Nanoparticles for gene therapy improve</title>
   	 <description>(PhysOrg.com) -- About five years ago, Professor Janet Sawicki at the Lankenau Institute in Pennsylvania read an article about nanoparticles developed by MIT's Robert Langer for gene therapy, the insertion of genes into living cells for the treatment of disease. Sawicki was working on treating ovarian cancer by delivering -- through viruses -- the gene for the diphtheria toxin, which kills tumor cells.</description>
     <link>http://www.physorg.com/news176720244.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Fri, 06 Nov 2009 08:58:32 EST</pubDate>
	 <guid isPermaLink="false">news176720244</guid>
</item>
<item>
     <title>Metals could forge new cancer drug</title>
   	 <description>Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.</description>
     <link>http://www.physorg.com/news175157795.html</link>
	 <category>Chemistry</category>
	 <pubDate>Mon, 19 Oct 2009 07:57:05 EST</pubDate>
	 <guid isPermaLink="false">news175157795</guid>
</item>
<item>
     <title>Breast cancer patients with high risk gene diagnosed six years earlier than generation before</title>
   	 <description>Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://www.physorg.com/news174325552.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 09 Oct 2009 16:46:16 EST</pubDate>
	 <guid isPermaLink="false">news174325552</guid>
</item>
<item>
     <title>Cancer predisposition from genetic variation shows strong gender bias</title>
   	 <description>(PhysOrg.com) -- Cancer predisposition resulting from the presence of a specific gene variant shows a strong gender bias, researchers at the University of Cincinnati (UC) have demonstrated.</description>
     <link>http://www.physorg.com/news172770958.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Sep 2009 16:56:19 EST</pubDate>
	 <guid isPermaLink="false">news172770958</guid>
</item>
<item>
     <title>The Medical Minute: Preservation of fertility -- gynecologic cancer</title>
   	 <description>In recent years, several new innovations have been employed in the treatment for women with gynecologic cancer in an effort to preserve fertility. These innovations consist of conservative ovarian staging, embryo/oocyte cryopreservation, hormonal treatment of endometrial cancer, and fertility-sparing radical hysterectomy for women with cervical cancer.</description>
     <link>http://www.physorg.com/news171212613.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 03 Sep 2009 16:08:48 EST</pubDate>
	 <guid isPermaLink="false">news171212613</guid>
</item>
<item>
     <title>Scientists find genetic marker associated with ovarian cancer risk</title>
   	 <description>A new genetic marker associated with ovarian cancer risk was recently discovered by an international research group, led by scientists from the Cancer Research Genetic Epidemiology Unit in the United Kingdom.  Drs. Marc Goodman, Galina Lurie, Michael Carney, and Keith Terada of the University of Hawai'i at M&amp;#257;noa's Cancer Research Center of Hawai'i participated in the validation of the discovered genetic marker as a part of the Ovarian Cancer Association Consortium, a worldwide forum of scientists performing ovarian cancer research.</description>
     <link>http://www.physorg.com/news171047151.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 18:30:06 EST</pubDate>
	 <guid isPermaLink="false">news171047151</guid>
</item>
<item>
     <title>New treatment in sight for ovarian cancer</title>
   	 <description>In the future, women with metastatic ovarian cancer could  be treated with a radioactive substance that can seek and destroy tumour cells. An initial study in patients conducted jointly by the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital has found that the treatment has no unwanted side-effects.</description>
     <link>http://www.physorg.com/news170947692.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Aug 2009 14:40:02 EST</pubDate>
	 <guid isPermaLink="false">news170947692</guid>
</item>
<item>
     <title>More than half of women with ovarian cancer face delay in diagnosis</title>
   	 <description>(PhysOrg.com) -- Many women with ovarian cancer can go undiagnosed for months because their symptoms are not always being investigated promptly, warn researchers at the University of Bristol in a study published on BMJ website today.</description>
     <link>http://www.physorg.com/news170518875.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 26 Aug 2009 15:21:44 EST</pubDate>
	 <guid isPermaLink="false">news170518875</guid>
</item>
<item>
     <title>Cornell makes cancer vaccine for clinical use</title>
   	 <description>The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein -a cancer vaccine -that will be used in clinical trials for patients facing either ovarian cancer or melanoma.  The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.</description>
     <link>http://www.physorg.com/news170013469.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 Aug 2009 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news170013469</guid>
</item>
<item>
     <title>Research Team Designing Holographic Imaging System for Ovarian Cancer</title>
   	 <description>Two University of Arizona researchers have formed a research team to design, build and evaluate two versions of an ovarian cancer medical imaging and screening instrument that will use holographic components in a new type of optical microscope.</description>
     <link>http://www.physorg.com/news169148323.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 11 Aug 2009 02:40:01 EST</pubDate>
	 <guid isPermaLink="false">news169148323</guid>
</item>
<item>
     <title>Young early stage ovarian cancer patients can preserve fertility</title>
   	 <description>A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. The study is published in the September 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. </description>
     <link>http://www.physorg.com/news169103878.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 07:00:02 EST</pubDate>
	 <guid isPermaLink="false">news169103878</guid>
</item>
<item>
     <title>Women often opt to surgically remove their breasts, ovaries  to reduce cancer risk</title>
   	 <description>Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers &amp; Prevention, a journal of the American Association for Cancer Research.</description>
     <link>http://www.physorg.com/news168764875.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 06 Aug 2009 10:10:03 EST</pubDate>
	 <guid isPermaLink="false">news168764875</guid>
</item>
<item>
     <title>Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth (w/ Video)</title>
   	 <description>Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.</description>
     <link>http://www.physorg.com/news168149704.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Jul 2009 05:21:34 EST</pubDate>
	 <guid isPermaLink="false">news168149704</guid>
</item>
<item>
     <title>EphA2-targeted therapy delivers chemo directly to ovarian cancer cells</title>
   	 <description>With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovarian cancer cells. Using the EphA2 protein as a molecular homing mechanism, chemotherapy was delivered in a highly selective manner in preclinical models of ovarian cancer, the researchers report in the July 29 issue of the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news168106425.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Jul 2009 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news168106425</guid>
</item>
<item>
     <title>Tiny early-stage ovarian tumors define early detection challenge</title>
   	 <description>A new study by Howard Hughes Medical Institute researchers shows that most early-stage ovarian tumors exist for years at a size that is a thousand times smaller than existing tests can detect reliably.</description>
     <link>http://www.physorg.com/news167977265.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Jul 2009 05:21:47 EST</pubDate>
	 <guid isPermaLink="false">news167977265</guid>
</item>
<item>
     <title>Trojan horse for ovarian cancer -- nanoparticles turn immune system soldiers against tumor cells</title>
   	 <description>In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor.</description>
     <link>http://www.physorg.com/news166891473.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Wed, 15 Jul 2009 15:44:58 EST</pubDate>
	 <guid isPermaLink="false">news166891473</guid>
</item>
<item>
     <title>Better tools needed to detect ovarian cancer, report concludes</title>
   	 <description>Numerous times after Amy Brannock was diagnosed and treated for ovarian cancer, a screening test showed her illness remained in remission.</description>
     <link>http://www.physorg.com/news166337888.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Jul 2009 06:50:01 EST</pubDate>
	 <guid isPermaLink="false">news166337888</guid>
</item>
<item>
     <title>Two reproductive factors are important predictors of death from ovarian cancer</title>
   	 <description>Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.</description>
     <link>http://www.physorg.com/news166337389.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Jul 2009 06:20:02 EST</pubDate>
	 <guid isPermaLink="false">news166337389</guid>
</item>
<item>
     <title>Why are African-Americans less likely to survive certain cancers?</title>
   	 <description>African Americans are more likely than other races to die from breast, prostate and ovarian cancers, but this disparity is not due to poverty or inferior healthcare, a first-of-its-kind study has found.</description>
     <link>http://www.physorg.com/news166204767.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 07 Jul 2009 17:00:28 EST</pubDate>
	 <guid isPermaLink="false">news166204767</guid>
</item>
<item>
     <title>Platypus link to ovarian cancer</title>
   	 <description>(PhysOrg.com) -- Researchers from the Royal Adelaide Hospital and University of Adelaide believe our oldest mammalian relative may help us to better understand ovarian cancer. </description>
     <link>http://www.physorg.com/news165241632.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 26 Jun 2009 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news165241632</guid>
</item>
<item>
     <title>Found: 1 in 3 billion</title>
   	 <description>Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer.</description>
     <link>http://www.physorg.com/news163904357.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Jun 2009 02:00:54 EST</pubDate>
	 <guid isPermaLink="false">news163904357</guid>
</item>
<item>
     <title>Cancer: The cost of being smarter than chimps?</title>
   	 <description>Are the cognitively superior brains of humans, in part, responsible for our higher rates of cancer? That's a question that has nagged at John McDonald, chair of Georgia Tech's School of Biology and chief research scientist at the Ovarian Cancer Institute, for a while. Now, after an initial study, it seems that McDonald is on to something. The new study is available online in the journal Medical Hypothesis and will appear in the forthcoming issue of the journal.</description>
     <link>http://www.physorg.com/news163844146.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 09:16:18 EST</pubDate>
	 <guid isPermaLink="false">news163844146</guid>
</item>
<item>
     <title>Patenting human genes thwarts research, scientists say</title>
   	 <description>Rapid advances in biology and genetics are raising fresh concerns about the spreading practice of patenting human genes.</description>
     <link>http://www.physorg.com/news163334329.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Jun 2009 11:39:25 EST</pubDate>
	 <guid isPermaLink="false">news163334329</guid>
</item>
<item>
     <title>Stem cell protein offers a new cancer target</title>
   	 <description>A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.</description>
     <link>http://www.physorg.com/news163081825.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 13:33:06 EST</pubDate>
	 <guid isPermaLink="false">news163081825</guid>
</item>
<item>
     <title>Genetic testing for breast or ovarian cancer risk may be greatly underutilized</title>
   	 <description>Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers.  In a report in the Journal of General Internal Medicine, which has been released online, investigators from the Massachusetts General Hospital (MGH) Institute of Health Policy and Dana-Farber Cancer Institute note that their findings illustrate the challenges of bringing genetic information into real-world clinical practice.</description>
     <link>http://www.physorg.com/news162133220.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 21 May 2009 14:01:36 EST</pubDate>
	 <guid isPermaLink="false">news162133220</guid>
</item>
<item>
     <title>Mothers satisfied when they share cancer genetic test results with children</title>
   	 <description>Mothers who share cancer genetic test results with their children are more satisfied with their decision than those who decide not to tell, according to a new study by researchers at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.  The study also shows, for the first time, what role fathers play in disclosing mother's test results.  These findings will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando May 29 - June 2.</description>
     <link>http://www.physorg.com/news161544198.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 14 May 2009 18:23:43 EST</pubDate>
	 <guid isPermaLink="false">news161544198</guid>
</item>
<item>
     <title>Spain allows embryo selection to screen for cancer genes</title>
   	 <description> Health authorities in Spain said Wednesday they had authorised the genetic screening of pre-implantation embryos to ensure they do not carry genes that might cause cancer.</description>
     <link>http://www.physorg.com/news159609905.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Apr 2009 09:05:34 EST</pubDate>
	 <guid isPermaLink="false">news159609905</guid>
</item>
<item>
     <title>New study questions routine removal of ovaries along with hysterectomy</title>
   	 <description>Women who have their healthy ovaries removed when they have a hysterectomy face a higher risk of death, including death from coronary heart disease and lung cancer, than women who keep their ovaries, according to new research.</description>
     <link>http://www.physorg.com/news159557639.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 18:34:20 EST</pubDate>
	 <guid isPermaLink="false">news159557639</guid>
</item>


</channel>
</rss>

